Autres langues Amarin Corporation plc

Actions

AMRN

US0231114044

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 27/07/2026			Varia. 5j.	Varia. 1 janv.
13,81 ^USD	+1,92%		+1,54%	-1,04%

02/07	Les actions europeennes cotees aux Etats-Unis sous forme d'ADR progressent fortement lors de la seance de jeudi	MT
30/06	Amarin Corporation plc réaffirme le rôle éprouvé et recommandé par les recommandations cliniques de Vascepa (icosapent éthyl) dans un paysage en évolution des traitements des triglycérides	CI

Autres langues

15/07	Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
02/07	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
30/06	Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
30/06	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
29/06	European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
23/06	Top cases on the US Supreme Court's docket
22/06	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
18/06	European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
09/06	European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
08/06	European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
05/06	Afternoon Meeting: Los datos de empleo complican la labor de la Fed
05/06	The Jobs Report Just Made the Fed's Life Harder
05/06	To infinity and beyond
04/06	Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
04/06	Top cases on the US Supreme Court's docket
04/06	Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
04/06	Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
28/05	European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
27/05	New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
27/05	Amarin Corporation plc Presents New REDUCE-IT Analysis At European Atherosclerosis Society Congress 2026
26/05	European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
18/05	European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
14/05	European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading
11/05	European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
04/05	European Equities Traded in the US as American Depositary Receipts Start Week Lower